WDM(SH:600055) Xin Lang Cai Jing·2025-08-22 11:55Group 1 - The core point of the announcement is that Beijing Wandong Medical Technology Co., Ltd. plans to repurchase shares to enhance its long-term incentive mechanism, motivate employees, and promote sustainable development [1] - The repurchase amount is set between RMB 30 million and RMB 60 million, funded by the company's own resources [1] - The maximum repurchase price is capped at RMB 25 per share, which does not exceed 150% of the average trading price over the 30 trading days prior to the board's decision [1] - The estimated number of shares to be repurchased ranges from 1.2 million to 2.4 million, representing 0.17% to 0.34% of the total share capital [1] - The repurchased shares will be used for employee stock ownership plans or equity incentives, and the repurchase will be conducted through centralized bidding [1] - The repurchase period is set for 12 months from the date the board approves the plan [1] Group 2 - Company executives, major shareholders, and actual controllers have no plans to reduce their holdings in the next 3 to 6 months [2] - If any share reduction plans are proposed in the future, the relevant parties and the company will strictly fulfill their information disclosure obligations [2]